Meet Merge Labs – a research lab with the long-term mission of bridging biological and artificial intelligence to maximize human ability, agency, and experience.
We’re pursuing this goal by developing fundamentally new approaches to brain-computer interfaces that interact with the brain at high bandwidth, integrate with advanced AI, and are ultimately safe and accessible for anyone to use.
Our individual experience of the world arises from billions of active neurons. If we can interface with these neurons at scale, we could restore lost abilities, support healthier brain states, deepen our connection with each other, and expand what we can imagine and create alongside advanced AI.
We believe this requires increasing the bandwidth and brain coverage of BCIs by several orders of magnitude while making them much less invasive. To make this happen, we’re developing entirely new technologies that connect with neurons using molecules instead of electrodes, transmit and receive information using deep-reaching modalities like ultrasound, and avoid implants into brain tissue. Recent breakthroughs in biotechnology, hardware, neuroscience, and computing made by our team and others convince us that this is possible.
We envision future BCIs that are equal parts biology, device, and AI in a form factor that we ourselves want to use and is broadly accessible. Fully realizing this vision demands that we think in decades rather than years, tackle very hard problems across disciplines, and be proactive in ensuring that the resulting technology is safe, privacy preserving, accessible, and beneficial to users and society. We embrace these challenges because we believe the benefits will massively outweigh the difficulties of getting there, and that a focused effort will bring these benefits to reality sooner.
We’re starting out as a research lab striving to bring together the smartest, most motivated people building the future of BCI. Together, we will push the frontiers of molecular engineering, hardware and understanding of brain function at scale. We will update our technical approaches based on data and seek to shorten timeframes. Our ultimate measure of success is creating real products that people love – initially to help patients with injury or disease and later to more broadly advance human capability. Along the way, we’ll share our progress and tools with the world to enable wider discovery.
If you’re excited to contribute to this mission, we’d love to meet you!